Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis.

Benitez Amaro, Aleyda; Solanelles Curco, Angels; Garcia, Eduardo; Julve, Josep; Rives, Jose; Benitez, Sonia; Llorente Cortes, Vicenta

Benitez Amaro, Aleyda; Solanelles Curco, Angels; Garcia, Eduardo; Julve, Josep; Rives, Jose; Benitez, Sonia; Llorente Cortes, Vicenta.

Afiliação

Benitez Amaro A; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Spain.
Solanelles Curco A; Biomedical Research Institute Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.
Garcia E; Biomedical Research Institute Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.
Julve J; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Spain.
Rives J; Biomedical Research Institute Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.
Benitez S; Metabolic Basis of Cardiovascular Risk Group, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Llorente Cortes V; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.

J Clin Med ; 10(16)2021 Aug 13.

Article em En | MEDLINE | ID: mdl-34441867

Palavras-chave

LDL; apolipoproteins; atherosclerosis; clinical trials; peptides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google